Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data

• প্রধান লেখক: Gils Roex (লেখক), Tom Feys (লেখক), Yves Beguin (লেখক), Tessa Kerre (লেখক), Xavier Poiré (লেখক), Philippe Lewalle (লেখক), Peter Vandenberghe (লেখক), Dominique Bron (লেখক), Sébastien Anguille (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2020-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological malignancies, including B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (ALL). The treatment is currently also being...